Literature DB >> 7983188

The endless story of the glial fibrillary acidic protein.

W J Chen1, R K Liem.   

Abstract

All intermediate filament proteins consist of an alpha-helical rod domain flanked by non-helical N-terminal head and C-terminal tail domains. The roles of the non-helical domains of various intermediate filament proteins in the assembly and co-assembly of higher-order filamentous structures have been studied by many groups but with quite contradictory results. Type III intermediate filaments are unique in that they can form homopolymers both in vitro and in vivo. The expression and assembly characteristics of carboxy- and amino-terminal deletion mutants of glial fibrillary acidic protein (GFAP), an astrocyte-specific type III intermediate filament protein, were examined by transient transfections of either vimentin-positive or vimentin-negative variants of human adrenocarcinoma-derived SW13 cell lines. Whereas complete deletion of the C-terminal tail domain of GFAP results in the formation of polymorphic aggregates, both intranuclear and cytoplasmic in self-assembly experiments, efficient co-assembly of these tail-less GFAP mutants with vimentin can be achieved as long as the KLLEGEE sequence at the C-terminal end of the rod domain is preserved. Up to one-fifth of the C-terminal end of the tail domain can be deleted without affecting the capability of GFAP to self-assemble. The highly conserved RDG-containing motif in the tail domain may be important for self-assembly but is not sufficient. The entire head domain seems to be required for self-assembly. All N-terminal deletion mutants of GFAP share the same phenotype of diffuse cytoplasmic staining when expressed in vimentin-negative SW13 cells. Although co-assembly with vimentin can still be achieved with completely head-less GFAP, preservation of some of the head domain greatly enhanced the efficiency. Our results form the basis for further, more detailed mapping of the essential regions in filament assembly of GFAP and other type III IFs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983188     DOI: 10.1242/jcs.107.8.2299

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  14 in total

1.  Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.

Authors:  Yi-Song Chen; Suh-Ciuan Lim; Mei-Hsuan Chen; Roy A Quinlan; Ming-Der Perng
Journal:  Exp Cell Res       Date:  2011-07-02       Impact factor: 3.905

Review 2.  Intermediate filaments in the nervous system: implications in cancer.

Authors:  C L Ho; R K Liem
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

3.  Identification of a novel nonsense mutation in the rod domain of GFAP that is associated with Alexander disease.

Authors:  Tai-Seung Nam; Jin Hee Kim; Chi-Hsuan Chang; Woong Yoon; Yoon Seok Jung; Sa-Yoon Kang; Boo Ahn Shin; Ming-Der Perng; Seok-Yong Choi; Myeong-Kyu Kim
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

4.  Archetypal and new families with Alexander disease and novel mutations in GFAP.

Authors:  Albee Messing; Rong Li; Sakkubai Naidu; J Paul Taylor; Lital Silverman; Daniel Flint; Marjo S van der Knaap; Michael Brenner
Journal:  Arch Neurol       Date:  2011-10-10

5.  The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27.

Authors:  Ming Der Perng; Mu Su; Shu Fang Wen; Rong Li; Terry Gibbon; Alan R Prescott; Michael Brenner; Roy A Quinlan
Journal:  Am J Hum Genet       Date:  2006-06-12       Impact factor: 11.025

6.  Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by alphaB-crystallin.

Authors:  Y Koyama; J E Goldman
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

7.  The S100B protein inhibits phosphorylation of GFAP and vimentin in a cytoskeletal fraction from immature rat hippocampus.

Authors:  D R Ziegler; C E Innocente; R B Leal; R Rodnight; C A Gonçalves
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

8.  Glial fibrillary acidic protein filaments can tolerate the incorporation of assembly-compromised GFAP-delta, but with consequences for filament organization and alphaB-crystallin association.

Authors:  Ming-Der Perng; Shu-Fang Wen; Terry Gibbon; Jinte Middeldorp; Jacqueline Sluijs; Elly M Hol; Roy A Quinlan
Journal:  Mol Biol Cell       Date:  2008-08-06       Impact factor: 4.138

9.  Reexpression of glial fibrillary acidic protein rescues the ability of astrocytoma cells to form processes in response to neurons.

Authors:  W J Chen; R K Liem
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

10.  Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation.

Authors:  Mei-Hsuan Chen; Tracy L Hagemann; Roy A Quinlan; Albee Messing; Ming-Der Perng
Journal:  ASN Neuro       Date:  2013-11-19       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.